A comprehensive view of Men's Health Issues. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

University of Michigan researchers have developed a urine-based test, MyProstateScore2.0, that differentiates between slow growing and aggressive forms of prostate cancer; the test could reduce unnecessary biopsies by around 41%
Published: April 19, 2024 by University of Michigan Institute for Healthcare Policy & Innovation
Olympus reports positive policy changes by commercial payers is extending coverage for iTind, its minimally invasive treatment for benign prostatic hyperplasia; policy updates may affect up to 27 million enrollees in the US
Published: April 15, 2024 by Olympus America Inc.
Arvinas secures over US$1.0B deal with Novartis for the development and commercialization of its second-gen prostate cancer treatment ARV-766; Arvinas is also eligible for an additional US$1.01B in development, regulatory, and commercial milestones
Published: April 11, 2024 by Invezz
Novartis to file for Pluvicto pre-taxane label expansion in H2 2024 after updated survival results show hazard ratio less than 1.0; full results to be presented at upcoming medical congress
Published: April 05, 2024 by Contify Life Science News
American Cancer Society and Pfizer fund US$15.0M project 'Change the Odds' for underserved communities to address disparity in cancer care; program to focus on breast and prostate cancer
Published: February 06, 2024 by Managed Healthcare Executive

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count